TREATMENT OUTCOME OF ELDERLY NASOPHARYNGEAL CARCINOMA PATIENTS IN VIETNAM NATIONAL CANCER HOSPITAL

Thị Vân Anh Phạm1,, Chính Đại Lê1, Văn Đăng Nguyễn1,2, Thị Hằng Nguyễn2, Thanh Tùng Ngô3,4
1 HMU
2 K Hospital
3 VNU Hanoi-University of Medicine and Pharmacy
4 E Hospital

Main Article Content

Abstract

Purpose: To describe some clinical, subclinical characteristics and the treatment outcome of elderly nasopharyngeal carcinoma patients at Viet Nam national cancer hospital. Methods: A retrospective study on 96 patients with brain metastatic breast cancer in the National cancer hospital from 2018 to 2022. Results: The mean age of the patients was 65.8 years old, more men than women with a ratio of 3/1. Most patients came to the hospital within 3 months of having symptoms with a rate of 53.1% with the most common symptom being cervical lymphadenopathy accounting for 64.6%. Most patients were diagnosed at stage II with a rate of 34.4%. The rate of complete response in tumors and lymph nodes at 4 weeks after the end of treatment was 84.4%. Overall survival was 55.4 ± 2.2 months, disease-free survival was 50.7 ± 2.6 months, and progression-free survival was 55.6 ± 2.2 months. The 3-year, 5-year OS rates are 88,9%, 65,5%. The 3-year, 5-year PFS rates are 88,4%,69,4%. The 3-year, 5-year DFS rates are 78,4% và 65,5%. Conclusion: The elderly’s nasopharyngeal cancer has similar clinical and subclinical characteristics to the general population. Treatment outcome is good, but still lower than the general population's.

Article Details

References

1. Liang Y, Chen K hua, Yang J, et al. Acute Toxicities and Prognosis of Elderly Patients with Nasopharyngeal Carcinoma After Intensity-Modulated Radiotherapy: Prediction with Nomogram. CMAR. 2020;Volume 12:8821-8832. doi:10.2147/CMAR.S261717
2. Lyu Y, Ni M, Zhai R, et al. Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Eur Arch Otorhinolaryngol. 2021;278(7):2549-2557. doi:10.1007/s00405-020-06399-5
3. Yeh SA, Hwang TZ, Wang CC, et al. Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Journal of Radiation Research. 2021;62(3):438-447. doi:10.1093/jrr/rrab008
4. Bùi Vinh Q. Nghiên cứu điều trị ung thư vòm họng giai đoạn III, IV(MO) bằng phối hợp hoá - xạ trị gia tốc 3 chiều theo hình dạng khối u. Luận án tiến sĩ y học-Ung thư học. Trường đại học Y Hà Nội
5. Huang Y, Chen W, Haque W, et al. The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis. Cancer Med. 2018;7(4):1093-1101. doi:10.1002/cam4.1377
6. Sommat K, Yit NLF, Wang F, Lim JHC. Impact of comorbidity on tolerability and survival following curative intent intensity modulated radiotherapy in older patients with nasopharyngeal cancer. Journal of Geriatric Oncology. 2018;9(4):352-358. doi:10.1016/ j.jgo.2018.01.006
7. Lu T, Xiong X, Zhong F, Gong X, Li J. Intensity modulated radiation therapy in elderly patients with nasopharyngeal carcinoma. Holist Integ Oncol. 2023;2(1):20. doi:10.1007/s44178-023-00047-8
8. Au KH, Ngan RKC, Ng AWY, et al. Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study). Oral Oncology. 2018; 77:16-21. doi:10.1016/j.oraloncology.2017.12.004